Lantheus Holdings Ownership
| LNTH Stock | USD 93.25 13.20 16.49% |
Shares in Circulation | First Issued 2012-12-31 | Previous Quarter 73.1 M | Current Value 69.2 M | Avarage Shares Outstanding 45.7 M | Quarterly Volatility 19.4 M |
Lantheus |
Lantheus Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.61. Lantheus Holdings recorded earning per share (EPS) of 7.01. The entity had not issued any dividends in recent years. Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts. Lantheus Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 612 people. To find out more about Lantheus Holdings contact Mary Heino at 978 671 8001 or learn more at https://www.lantheus.com.Besides selling stocks to institutional investors, Lantheus Holdings also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Lantheus Holdings' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Lantheus Holdings' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Lantheus Holdings Quarterly Liabilities And Stockholders Equity |
|
Lantheus Holdings Insider Trades History
Roughly 3.0% of Lantheus Holdings are currently held by insiders. Unlike Lantheus Holdings' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Lantheus Holdings' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Lantheus Holdings' insider trades
Lantheus Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Lantheus Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lantheus Holdings backward and forwards among themselves. Lantheus Holdings' institutional investor refers to the entity that pools money to purchase Lantheus Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.3 M | Jpmorgan Chase & Co | 2024-09-30 | 1.1 M | Swedbank Ab | 2024-12-31 | 1.1 M | T. Rowe Price Associates, Inc. | 2024-12-31 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 985 K | Macquarie Group Ltd | 2024-12-31 | 982.9 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 973.9 K | Northern Trust Corp | 2024-12-31 | 916.4 K | Charles Schwab Investment Management Inc | 2024-12-31 | 814.2 K | Blackrock Inc | 2024-12-31 | 8.6 M | Vanguard Group Inc | 2024-12-31 | 7.2 M |
Lantheus Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Lantheus Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lantheus Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Lantheus Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lantheus Holdings Outstanding Bonds
Lantheus Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lantheus Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lantheus bonds can be classified according to their maturity, which is the date when Lantheus Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Lantheus Holdings Corporate Filings
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
| 12th of February 2025 Other Reports | ViewVerify | |
F4 | 11th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Lantheus Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lantheus Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lantheus Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lantheus Holdings Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantheus Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Lantheus Stock please use our How to Invest in Lantheus Holdings guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantheus Holdings. If investors know Lantheus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantheus Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 7.01 | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets |
The market value of Lantheus Holdings is measured differently than its book value, which is the value of Lantheus that is recorded on the company's balance sheet. Investors also form their own opinion of Lantheus Holdings' value that differs from its market value or its book value, called intrinsic value, which is Lantheus Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantheus Holdings' market value can be influenced by many factors that don't directly affect Lantheus Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantheus Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantheus Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantheus Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.